Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
2526
Palvella Therapeutics
PVLA
$2.15B
| $7.1M | ﹤0.01% |
314,989
+45,152
| +17% | +$1.06M |
|
2527
PUT
AeroVironment
AVAV
$7.42B
| $7.1M | ﹤0.01% |
24,900
-11,300
| -31% | -$1.91M |
|
2528
Evolent Health
EVH
$358M
| $7.09M | ﹤0.01% |
629,831
-840,369
| -57% | -$7.72M |
|
2529
CALL
Carrier Global
CARR
$50.6B
| $7.08M | ﹤0.01% |
96,800
+62,400
| +181% | +$4.23M |
|
2530
CALL
Futu Holdings
FUTU
$14.5B
| $7.08M | ﹤0.01% |
57,300
-3,200
| -5% | -$327K |
|
|
OSG
2531
Octave Specialty Group
OSG
$250M
| $7.07M | ﹤0.01% |
996,041
+487,355
| +96% | +$3.63M |
|
2532
CALL
Charles River Laboratories
CRL
$11.3B
| $7.06M | ﹤0.01% |
+46,500
| New | +$6.2M |
|
2533
PUT
Dow Inc
DOW
$21.7B
| $7.05M | ﹤0.01% |
266,100
-79,400
| -23% | -$2.31M |
|
2534
PUT
Johnson Controls International
JCI
$87.8B
| $7.04M | ﹤0.01% |
66,700
-199,800
| -75% | -$18.4M |
|
|
NPACU
2535
New Providence Acquisition Corp III Units
NPACU
$282M
| $7.04M | ﹤0.01% |
+673,497
| New | +$6.9M |
|
2536
AB InBev
BUD
$166B
| $7.02M | ﹤0.01% |
102,179
-840,763
| -89% | -$56.5M |
|
2537
PUT
Abercrombie & Fitch
ANF
$4.45B
| $6.99M | ﹤0.01% |
84,400
+41,300
| +96% | +$3.13M |
|
2538
CALL
NRG Energy
NRG
$28.3B
| $6.99M | ﹤0.01% |
43,500
-9,600
| -18% | -$1.27M |
|
2539
CALL
Glaukos
GKOS
$9.9B
| $6.97M | ﹤0.01% |
67,500
-13,500
| -17% | -$1.27M |
|
2540
Cogent Biosciences
COGT
$7.07B
| $6.96M | ﹤0.01% |
969,973
+455,475
| +89% | +$2.53M |
|
2541
CALL
NextNav
NN
$1.83B
| $6.96M | ﹤0.01% |
458,000
+50,000
| +12% | +$641K |
|
2542
Northern Oil and Gas
NOG
$2.27B
| $6.94M | ﹤0.01% |
244,839
+52,770
| +27% | +$1.42M |
|
|
BACCU
2543
Blue Acquisition Corp Unit
BACCU
$203M
| $6.93M | ﹤0.01% |
+690,000
| New | +$6.94M |
|
2544
Phillips Edison & Co
PECO
$5.45B
| $6.93M | ﹤0.01% |
197,688
-657,450
| -77% | -$23.3M |
|
2545
Manitowoc
MTW
$497M
| $6.92M | ﹤0.01% |
575,885
+414,968
| +258% | +$4.07M |
|
2546
PUT
Suncor Energy
SU
$78.8B
| $6.92M | ﹤0.01% |
157,600
+82,100
| +109% | +$2.97M |
|
2547
Trinity Capital Inc.
TRIN
$1.56B
| $6.92M | ﹤0.01% |
491,727
+127,450
| +35% | +$1.84M |
|
2548
CALL
Marriott International
MAR
$99B
| $6.91M | ﹤0.01% |
25,300
+300
| +1% | +$75.2K |
|
2549
CALL
Wayfair
W
$11.9B
| $6.9M | ﹤0.01% |
134,900
+1,900
| +1% | +$70.9K |
|
|
BCAX
2550
Bicara Therapeutics
BCAX
$1.73B
| $6.88M | ﹤0.01% |
741,019
+715,371
| +2,789% | +$8.53M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.